MedTrace Logo

Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation

NCT01724437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2022-09-01

No results posted yet for this study

Summary

to assess the near-term (12 months) efficacy of pulmonary vein isolation.

Conditions

  • Paroxysmal Atrial Fibrillation
  • Catheter Ablation Strategies

Interventions

DEVICE

catheter based pulmonary vein isolation

catheter based ablation using irrigated catheters and radiofrequency energy as in clinical practice

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Stephan Willems · Universitäres Herzzentrum Hamburg GmbH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-11-30
Completion
2012-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724437 on ClinicalTrials.gov